Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Director departure
Appointed director
CC transcript
Eterna Therapeutics Inc. (NTN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
08/10/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
Docs: "Dr. Angel Resignation Letter"
08/02/2023 8-K Investor presentation
Docs: "Eterna Therapeutics Investor Presentation – August 2023"
07/18/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Securities Purchase Agreement, by and among Eterna Therapeutics Inc. and the purchasers party thereto",
"Form of Senior Convertible Note",
"Form of Common Stock Purchase Warrant",
"Registration Rights Agreement, by and among Eterna Therapeutics Inc. and the purchasers party thereto"
07/13/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "First Amendment to Exclusive License Agreement, by and between Eterna Therapeutics Inc. and Factor Bioscience Limited"
07/11/2023 8-K Quarterly results
05/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "RE: Separation Agreement and General Release"
05/02/2023 8-K Quarterly results
03/20/2023 8-K Quarterly results
02/22/2023 8-K Quarterly results
01/26/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/10/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
01/04/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
12/06/2022 8-K Quarterly results
12/05/2022 8-K Quarterly results
11/25/2022 8-K Quarterly results
11/23/2022 8-K Quarterly results
11/22/2022 8-K Quarterly results
11/09/2022 8-K Quarterly results
10/24/2022 8-K Quarterly results
10/14/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Option Agreement, by and between Exacis Biotherapeutics, Inc. and Brooklyn ImmunoTherapeutics, Inc"
10/11/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ...
Docs: "Certificate of Amendment to the Company’s Restated Certificate of Incorporation, filed October 11, 2022 (Name Change)",
"Second Amended and Restated Bylaws of the Company",
"Certificate of Amendment to the Company’s Restated Certificate of Incorporation, filed October 11, 2022 (Reverse Stock Split)"
09/23/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
09/15/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Master Services Agreement, by and between Factor Bioscience Inc. and Brooklyn ImmunoTherapeutics, Inc"
08/05/2022 8-K Quarterly results
07/27/2022 8-K Quarterly results
07/01/2022 8-K Quarterly results
06/17/2022 8-K Quarterly results
06/07/2022 8-K Quarterly results
05/31/2022 8-K Quarterly results
05/27/2022 8-K Quarterly results
04/19/2022 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
Docs: "Marcum, LLP letter"
04/15/2022 8-K Quarterly results
Docs: "Press release of Brooklyn ImmunoTherapeutics, Inc. announcing the Company’s financial results for the three months and year ended December 21, 2021"
03/09/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy